Yang Yunqing, Zhang Huidan, Wanyan Yangke, Liu Kehang, Lv Tongtong, Li Man, Chen Yuqing
Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, Life Sciences College, Nanjing Normal University, 1# Wenyuan Road, Nanjing 210000, Jiangsu, P. R. China.
ACS Omega. 2020 Aug 20;5(34):21513-21523. doi: 10.1021/acsomega.0c02093. eCollection 2020 Sep 1.
Antimicrobial peptides (AMPs) are important anticancer resources, and exploring AMP conjugates as highly effective and selective anticancer agents would represent new progress in cancer treatment. In this study, we synthesized C4-C16 fatty-acyl-conjugated AMP CM4 and investigated its physiochemical properties and cytotoxicity activity in breast cancer cells. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and reversed-phase high-performance liquid chromatography (RP-HPLC) showed that long-chain fatty acyl (≥C12) conjugation prevented N-acyl-CM4 from trypsin hydrolysis. RP-HPLC and circular dichroism (CD) spectra showed that the hydrophobicity and helical content of N-acyl-CM4 increased with the acyl length. The acyl chain length was positively related to the cytotoxicity of C8-C16 conjugates, and C12-C16 fatty acyl conjugates exhibited significant cytotoxicity against MX-1, MCF-7, and MDA-MB-231 cells, with IC values <8 μM. Flow cytometry and confocal laser scanning microscopy results showed that N-acylated conjugation significantly increased the membrane affinity in breast cancer cells, and C12-C16 acyl conjugates were capable of translocating to the intracellular space, thereby targeting mitochondria and inducing apoptosis. N-acyl-CM4 showed low cytotoxicity against normal mammalian cells and erythrocytes, especially ≤C12 fatty acyl conjugates, exhibiting selective cytotoxicity to breast cancer cells. The current work indicated that increasing hydrophobicity by attaching long fatty acyl (≥C12) to AMPs may be an effective method to improve the anticancer activity, together with selectivity and resistance to trypsin hydrolysis. This finding provides a good strategy to develop AMPs as effective anticancer agents in the future.
抗菌肽(AMPs)是重要的抗癌资源,探索将AMPs缀合物作为高效且选择性的抗癌剂将代表癌症治疗的新进展。在本研究中,我们合成了C4 - C16脂肪酸酰基共轭的AMPCM4,并研究了其在乳腺癌细胞中的理化性质和细胞毒性活性。Tricine - 十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳(SDS - PAGE)和反相高效液相色谱(RP - HPLC)表明,长链脂肪酰基(≥C12)共轭可防止N - 酰基 - CM4被胰蛋白酶水解。RP - HPLC和圆二色性(CD)光谱表明,N - 酰基 - CM4的疏水性和螺旋含量随酰基长度增加。酰基链长度与C8 - C16缀合物的细胞毒性呈正相关,并且C12 - C16脂肪酰基缀合物对MX - 1、MCF - 7和MDA - MB - 231细胞表现出显著的细胞毒性,IC值<8μM。流式细胞术和共聚焦激光扫描显微镜结果表明,N - 酰化共轭显著增加了乳腺癌细胞中的膜亲和力,并且C12 - C16酰基缀合物能够转运到细胞内空间,从而靶向线粒体并诱导凋亡。N - 酰基 - CM4对正常哺乳动物细胞和红细胞表现出低细胞毒性,尤其是≤C12脂肪酰基缀合物,对乳腺癌细胞表现出选择性细胞毒性。目前的工作表明,通过将长脂肪酰基(≥C12)连接到AMPs上来增加疏水性可能是提高抗癌活性以及选择性和抗胰蛋白酶水解能力的有效方法。这一发现为未来开发AMPs作为有效的抗癌剂提供了一个良好的策略。